FDA Approves First mRNA Flu Vaccine for Adults Over 50, Enhancing Seasonal Flu Protection
Rapid Read

FDA Approves First mRNA Flu Vaccine for Adults Over 50, Enhancing Seasonal Flu Protection

What's Happening? The U.S. Food and Drug Administration (FDA) has approved the first mRNA flu vaccine, mFlusiva® produced by Moderna, for adults aged 50 and older. This marks a significant advancement in influenza vaccination technology. For the 2026-27 flu season, all U.S.-approved vaccine formulas
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.